Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) (English, HTML)
Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL): English HTML file. From Health Canada, updated Oct 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-10-29
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or its salts" on the Prescription Drug List (PDL). Note that both the human and veterinary parts of the PDL were revised with the addition of a qualifier.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file